AJOONI — Ajooni Biotech Balance Sheet
0.000.00%
Last trade - 00:00- IN₹649.36m
- IN₹815.80m
- IN₹1.82bn
Annual balance sheet for Ajooni Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.574 | 4.93 | 4.28 | 71 | 11.2 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 160 | 246 | 165 | 295 | 320 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 219 | 347 | 323 | 620 | 745 |
| Net Property, Plant And Equipment | 62.1 | 65.5 | 112 | 112 | 259 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 290 | 587 | 475 | 951 | 1,204 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 101 | 152 | 30.1 | 48.2 | 273 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 126 | 171 | 48.1 | 69.7 | 292 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 164 | 417 | 427 | 881 | 912 |
| Total Liabilities & Shareholders' Equity | 290 | 587 | 475 | 951 | 1,204 |
| Total Common Shares Outstanding |